Accelerator
Every published round Foundry took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Foundry has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for Foundry, as distinct from the investments it has made.
Companies Foundry has backed that another company then bought. An exit for the holding, not a deal Foundry did.
| Name | Role | Sources |
|---|---|---|
| Brad Feld | Partner | Eastend Ventures, Startup Daily |
Stories naming Foundry. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Eastend Ventures says Brad Feld, who co-founded Foundry and Techstars, will chair the LPAC of its Fund 1, alongside current committee members Sonya Brocklehurst and Dr Roger Voyle; first meeting May 2026.
US-Singapore biotech Allay Therapeutics has closed a $60 million Series C round led by Arboretum Ventures, with several healthcare investors taking part, to advance its long-acting post-surgical pain candidate into late-stage trials.